![Frédéric Collet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Collet
Direttore/Membro del Consiglio presso
ADVANCED ACCELERATOR APPLICATION SA(ADR)
Profilo
Frédéric Collet currently holds the positions of Chairman & Director General at Novartis Groupe France SAS, Chairman at Novartis Pharma SAS, and Non-Executive Director at Advanced Accelerator Applications SA since 2018.
The education history includes an undergraduate degree from Sciences Po conferred in 1989 and a graduate degree from Université Paris II Panthéon Assas conferred in 1986.
Posizioni attive di Frédéric Collet
| Società | Posizione | Inizio |
|---|---|---|
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Direttore/Membro del Consiglio | 01/01/2018 |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Develops gene therapies for patients with rare and life-threatening neurological genetic diseases | Presidente | - |
Novartis Groupe France SAS
 Novartis Groupe France SAS Financial ConglomeratesFinance Functions as an investment holding company | Amministratore Delegato | 30/03/2017 |
Eurazeo Capital
 Eurazeo Capital Investment ManagersFinance Eurazeo Capital invests in middle market companies located in Europe. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of debt and equity for growth and buyout capital requirements. The firm acquires minority stakes. | Consulente / Consigliere | 01/02/2023 |
Formazione di Frédéric Collet
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
82
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Eurazeo Capital
Eurazeo Capital Investment ManagersFinance Eurazeo Capital invests in middle market companies located in Europe. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of debt and equity for growth and buyout capital requirements. The firm acquires minority stakes. | Finance |
Sciences Po
 Sciences Po Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Groupe France SAS
Novartis Groupe France SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Université Paris II Panthéon Assas
 Université Paris II Panthéon Assas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma SAS
Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Develops gene therapies for patients with rare and life-threatening neurological genetic diseases | Health Technology |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops oncology, immunology and cardiovascular therapies | Health Technology |
